Moderate

Sjogren syndrome (Sjögren; sicca syndrome) — primary & secondary

Sjogren syndrome · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic autoimmune exocrinopathy with lymphocytic infiltration of lacrimal and salivary glands causing dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia). Primary (standalone) or secondary (with RA, SLE, systemic sclerosis). Associated with anti-Ro/SSA and anti-La/SSB, high ESR, polyclonal hypergammaglobulinaemia. Beyond sicca there is systemic disease: fatigue, arthralgia, cutaneous vasculitis, interstitial nephritis/distal RTA, ILD, peripheral neuropathy and a markedly increased risk of B-cell (MALT) lymphoma. Management is symptomatic for sicca and immunosuppressive for systemic/organ-threatening disease.

Red flags

  • Persistent/unilateral parotid or salivary gland enlargement, new lymphadenopathy — lymphoma until excluded
  • Palpable purpura, mononeuritis multiplex, falling complement — cryoglobulinaemic vasculitis
  • Flaccid weakness + hypokalaemia — distal RTA causing hypokalaemic paralysis
  • Progressive breathlessness — interstitial lung disease
  • Pregnant with anti-Ro: fetal bradycardia — congenital heart block

Assessment

Differential diagnosis

  • Age-related/medication-induced sicca (anticholinergics, antihistamines, diuretics)
  • IgG4-related disease (mikulicz — bilateral gland swelling, high IgG4, storiform fibrosis)
  • Sarcoidosis (parotid swelling, granulomas)
  • Chronic graft-versus-host disease; HIV/HCV-associated sicca (diffuse infiltrative lymphocytosis)
  • Amyloidosis; radiation sialadenitis

Investigations

  • Anti-Ro/SSA and anti-La/SSB, ANA, RF (RF often positive)
  • Schirmer test (<5 mm/5 min), ocular staining score; unstimulated salivary flow
  • ESR, FBC (cytopenias), immunoglobulins + serum protein electrophoresis (monoclonal band = lymphoma risk)
  • Complement C3/C4 and cryoglobulins (low complement/cryo = lymphoma/vasculitis risk)
  • Labial (minor) salivary gland biopsy — focal lymphocytic sialadenitis (focus score >=1) if serology negative
  • U&E + venous gas/urine pH (distal RTA), urinalysis; salivary gland ultrasound
  • Vigilance for persistent parotid swelling/lymphadenopathy — image + biopsy to exclude lymphoma

Management

  • Confirm diagnosis (2016 ACR/EULAR criteria: biopsy focus score, anti-Ro, ocular staining, Schirmer, salivary flow)
  • Dry eyes: artificial tears/gels, preservative-free; topical ciclosporin or short topical steroid for inflammation; punctal plugs; refer ophthalmology if severe
  • Dry mouth: frequent sips, sugar-free gum, saliva substitutes; aggressive dental caries prevention (fluoride, dental review); muscarinic agonists (pilocarpine/cevimeline) if residual gland function
  • Systemic symptoms (arthralgia, fatigue): hydroxychloroquine trial; NSAIDs for musculoskeletal pain
  • Organ-threatening disease (vasculitis, severe neuropathy, glomerulonephritis, ILD, severe cytopenias): glucocorticoids + immunosuppressant (azathioprine, mycophenolate, rituximab)
  • Treat distal renal tubular acidosis with potassium/bicarbonate replacement; monitor renal function
  • Pregnancy with anti-Ro/La: fetal medicine surveillance for congenital heart block; hydroxychloroquine reduces risk
  • Lifelong vigilance for lymphoma (persistent gland swelling, new monoclonal band, falling complement, cryoglobulins)

Drugs & doses

Preservative-free artificial tears/ocular lubricants as required; carmellose/hypromellose drops hourly if needed
Topical ciclosporin 0.05-0.1% eye drops twice daily for ocular surface inflammation [verify local]
Pilocarpine 5 mg ORALLY up to four times daily (or cevimeline 30 mg three times daily) for xerostomia if gland function retained — caution asthma/cardiac [verify local dose]
Saliva substitutes / high-fluoride toothpaste + sugar-free chewing gum for oral dryness and caries prevention
Hydroxychloroquine 200-400 mg ORALLY daily (max 5 mg/kg/day) for fatigue, arthralgia, cutaneous disease
Prednisolone 0.5-1 mg/kg/day ORALLY for active systemic/organ-threatening disease (then taper) [verify local dose]
Immunosuppressants: azathioprine 1-2.5 mg/kg/day, mycophenolate mofetil 1-1.5 g twice daily, or methotrexate as steroid-sparing [verify local]
Rituximab 1 g IV x2 (2 weeks apart) for refractory vasculitis, severe parotid disease or cryoglobulinaemia [verify local]
Potassium citrate / sodium bicarbonate replacement for distal renal tubular acidosis [verify local dose]

Disposition

Outpatient rheumatology; ophthalmology + dental co-management for sicca. Urgent referral/admission for organ-threatening disease (vasculitis, severe neuropathy, nephritis) or suspected lymphoma.

Complications & pitfalls

  • B-cell non-Hodgkin (MALT) lymphoma — up to ~5-10% lifetime, highest of any autoimmune disease
  • Dental caries, oral candidiasis, corneal ulceration
  • Distal renal tubular acidosis, interstitial nephritis, nephrocalcinosis
  • Peripheral/small-fibre neuropathy, ILD, cryoglobulinaemic vasculitis
  • Neonatal lupus / congenital heart block in anti-Ro positive pregnancy

Exam pearls

  • Sjogren carries the highest lymphoma risk of the autoimmune diseases — investigate any persistent gland swelling or new paraprotein.
  • Low C4, cryoglobulins, persistent parotid swelling and monoclonal gammopathy are the key lymphoma predictors.
  • Hydroxychloroquine is first-line for systemic fatigue/arthralgia; sicca itself is managed symptomatically (EULAR 2019/2020 recommendations).
  • Pilocarpine/cevimeline only help if residual gland function — useless in end-stage glands.
  • Anti-Ro in pregnancy mandates fetal cardiac monitoring; hydroxychloroquine lowers congenital heart block risk.
  • Think distal RTA in a Sjogren patient with unexplained hypokalaemia or nephrocalcinosis.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.